Unilateral ureteral obstruction causes gut microbial dysbiosis and metabolome disorders contributing to tubulointerstitial fibrosis

Abstract

Chronic kidney disease (CKD) increases the risk and prevalence of cardiovascular disease (CVD) morbidity and mortality. Recent studies have revealed marked changes in the composition of the microbiome and the metabolome and their potential influence in renal disease and CVD via the accumulation of microbial-derived uremic toxins. However, the effect of unilateral ureteral obstruction (UUO) on the gut microbiome and circulating metabolites is unknown. Male Sprague-Dawley rats were randomized to UUO and sham-operated control groups. Renal histology, colonic microbiota, and plasma metabolites were examined two weeks later. We employed 16S rRNA sequence and untargeted metabolomic analyses to explore the changes in colonic microbiota and plasma metabolites and their relationship with tubulointerstitial fibrosis (TIF). The UUO rats exhibited tubular atrophy and dilatation, interstitial fibrosis and inflammatory cell infiltration in the obstructed kidney. UUO rats showed significant colonic enrichment and depletion of genera. Significant differences were identified in 219 plasma metabolites involved in lipid, amino acid, and bile acid metabolism, which were consistent with gut microbiota-related metabolism. Interestingly, tryptophan and its metabolites kynurenine, 5-hydroxytryptophan and 5-hydroxytryptamine levels, which were linked with TIF, correlated with nine specific genera. Plasma tryptophan level was positively correlated with Clostridium IV, Turicibacter, Pseudomonas and Lactobacillales, and negatively correlated with Oscillibacter, Blautia, and Intestinimonas, which possess the genes encoding tryptophan synthase (K16187), indoleamine 2,3-dioxygenase (K00463) and tryptophan 2,3-dioxygenase (K00453) and their corresponding enzymes (EC:1.13.11.52 and EC:1.13.11.11) that exacerbate TIF. In conclusion, UUO results in profound changes in the gut microbiome and circulating metabolites, events that contribute to the pathogenesis of inflammation and TIF.

Dysbiotic gut microbes may contribute to hypertension by limiting vitamin D production

“…Excessive uremic toxins are produced as a result of GM alteration, which are implicated in the kidney disease development. Dysbiotic GM and metabolites can contribute to tubulointerstitial fibrosis, which might be mediated by tryptophan‐derived metabolite‐induced inflammation and oxidative stress . Meanwhile, the interaction between the gut epithelia and some commensal bacteria induces the rapid generation of reactive oxygen species, which participate in the development of nonalcoholic fatty liver disease …”

Small molecule inhibitors of epithelial‐mesenchymal transition for the treatment of cancer and fibrosis

“…Fries showed significant antitumor, diuretic, and renoprotective effects . Our recent study demonstrated that ergone inhibited NF‐κB signaling and α‐SMA expression in 5/6 nephrectomised and unilateral ureteral obstruction rats (Figure and Table ).…”

Discrimination of Different Parts of Saffron by Metabolomic‐Based Ultra‐Performance Liquid Chromatography Coupled with High‐Definition Mass Spectrometry

“…Metabolomics (or metabonomics) belong to one of component of systems biology. Recent technological advances have enabled rapid and systematic identification of a large myriad of metabolites or compounds by using sensitive and high‐throughput metabolomic techniques . Metabolomics has the potential to facilitate an understanding and illuminating of the action mechanisms of TCM .…”

“…Recent technological advances have enabled rapid and systematic identification of a large myriad of metabolites or compounds by using sensitive and high-throughput metabolomic techniques. [19][20][21][22][23][24] Metabolomics has the potential to facilitate an understanding and illuminating of the action mechanisms of TCM. [25] Although various mass spectrometry platforms could be used for metabolomics, ultra-performance liquid chromatography coupled with high-definition mass spectrometry (UPLC-HDMS) has been considered to be more suitable for analyzing the metabolite profiling and metabolite identification due to its enhanced reproducibility of retention time.…”